1. Home
  2. PBHC vs CELU Comparison

PBHC vs CELU Comparison

Compare PBHC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathfinder Bancorp Inc. (MD)

PBHC

Pathfinder Bancorp Inc. (MD)

N/A

Current Price

$13.77

Market Cap

92.9M

Sector

Finance

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.22

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PBHC
CELU
Founded
1859
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.9M
34.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PBHC
CELU
Price
$13.77
$1.22
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
3.2K
85.7K
Earning Date
01-30-2026
11-14-2025
Dividend Yield
2.83%
N/A
EPS Growth
N/A
N/A
EPS
1.07
N/A
Revenue
$44,154,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
$13.14
N/A
Revenue Growth
24.40
N/A
52 Week Low
$13.35
$1.00
52 Week High
$17.60
$4.35

Technical Indicators

Market Signals
Indicator
PBHC
CELU
Relative Strength Index (RSI) 41.91 35.46
Support Level $13.45 $1.01
Resistance Level $14.11 $1.37
Average True Range (ATR) 0.40 0.15
MACD -0.04 -0.02
Stochastic Oscillator 26.75 27.97

Price Performance

Historical Comparison
PBHC
CELU

About PBHC Pathfinder Bancorp Inc. (MD)

Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: